Breathe Well Live Well
|
Development of a core outcome set for clinical trials in childhood asthma: a …
7thSpace Interactive (press release) Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people – up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment … |
View full post on asthma – Google News
 Michigan Business Review – MLive.com |
Hundreds of clinical trials in Michigan are addressing asthma, heart …
Michigan Business Review – MLive.com Some clinical trials have trouble recruiting patients due to risks, complexity and other factors. |
View full post on asthma – Google News
|
MediciNova Asthma Compound Poised for Late-Stage Trials
San Diego Business Journal By Julie Gallant Tuesday, May 29, 2012 Local biopharmaceutical company MediciNova Inc. received enough positive news from a phase 2b clinical trial evaluating its MN-221 asthma compound to pursue planning for phase 3 trials. |
View full post on asthma – Google News
|
Children Usually Excluded From Clinical Drug Trials: Study
MSN Health & Fitness In a new study, researchers looked at all clinical trials registered worldwide from 2006 to 2011 for drugs to treat these common conditions: asthma, migraine headaches, schizophrenia, depression, diarrheal illness, lower respiratory infection, malaria, … |
View full post on asthma – Google News
|
Asthma vaccine hopes rise in preclinical trials
FierceVaccines Asthma's more than just a childhood wheeze–it's a chronic inflammatory disease often triggered by allergies that affects the breathing and causes around 284000 deaths a year worldwide, according to the World Health Organization (WHO). Allergic Asthma? There's a Shot for That |
View full post on asthma – Google News
 The Voice of Russia |
Asthma vaccine to go to clinical trials
The Voice of Russia French scientists have come up with a vaccine against asthma, reports the French newspaper La Croix. At present moment the vaccine is still being developed but in the coming 3-4 years the scientists are planning to start its clinical trials. |
View full post on asthma – Google News
|
Targacept reports mixed data from two trials
Reuters * Says asthma trial meets main goals * Says diabetes trial did not meet main goal * Targacept drops development of drug for diabetes March 27 (Reuters) – Targacept said an experimental drug proved effective in a mid-stage asthma trial, but failed to … Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of … Targacept Dropping Development Of Diabetes Drug; Shares Fall Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987 |
View full post on asthma – Google News
 Reuters UK |
Glaxo on the slide after trials setback for asthma drug
Evening Standard But clinical trials have not shown the new treatment to be better than GSK's flagship asthma drug Advair. "The results aren't a home run but look adequate for filing and approval," said pharma analyst Emmanuel Papadakis at Collins Stewart. … GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies … GSK to seek approval of Theravance lung drug For COPD, Glaxo intends to submit regulatory applications in the US and Europe … |
View full post on asthma – Google News
 Proactive Investors USA & Canada |
AstraZeneca Pays Dynavax $3M to Speed Up Start of Asthma Drug Trials
Genetic Engineering News Dynavax Technologies will receive a $3 million payment from AstraZeneca to fund the initiation of clinical trials with their partnered asthma drug AZD 1419. The payment comes as part of the firms' amended collaboration to accelerate the start of … AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug Dynavax and AstraZeneca to Advance TLR-9 Agonist Into Clinic for Asthma Dynavax Technologies Corporation partners with AstraZeneca to advance AZD 1419 … |
View full post on asthma – Google News
 Moneycontrol.com |
Glenmark starts Revamilast Phase IIb trials
Pharmaceutical Business Review Indian drug maker Glenmark Pharmaceuticals has started Phase IIb trials to evaluate Revamilast (GRC 4039) as a treatment for inflammatory disorders like rheumatoid arthritis (RA) and asthma. The trials aim to determine the safety and efficacy profile … Glenmark starts Phase-IIb human trials of Revamilast molecule Glenmark starts phase IIb human trials of molecule Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule … |
View full post on asthma – Google News